Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: Implications for clinical practice

Heart

Volumn 78, Issue 6, 1997, Pages 594-597

  Murdoch, David R ^a,b   Byrne, John ^b   Morton, James J ^a   McDonagh, Theresa A ^a,b   Robb, Stephen D ^a   Clements, Suzanne ^a   Ford, Ian ^a   McMurray, John J V ^b   Dargie, Henry J ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Diagnosis; Heart failure

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; RADIOIMMUNOASSAY;

EID: 0031451960     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.6.594     Document Type: Article

References (21)

1. Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990;323:757-8.
2. Lerman A, Gibbons RJ, Rodeheffer RJ, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341: 1105-9.
3. Darbar D, Davidson NC, Gillespie N, et al. Diagnostic-value of b-type natriuretic peptide concentrations in patients with acute myocardial-infarction. Am J Cardiol 1996;78:284-7.
4. Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994; 343:440-4.
5. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 1993;341:1109-13.
6. Struthers AD. Prospects for using a blood sample in the diagnosis of heart failure. Q J Med 1995;88:303-6.
7. Struthers AD. Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations? Br Heart J 1993;70:397-8.
8. Struthers AD. 10 years of natriuretic peptide research - a new dawn for their diagnostic and therapeutic use. BMJ 1994;308:1615-19.
9. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989;13:1534-9.
10. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 1990;82:1730-6.
11. Hall C, Rouleau JL, Moye L, et al. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation 1994;89: 1934-42.
12. Arakawa N, Nakamura M, Aoki H, Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996;27:1656-61.
13. Kono M, Yamauchi A, Tsuji T, et al. An immunoradiometric assay for brain natriuretic peptide in human plasma. Kaku Igaku Gijutsu 1993;13:2-7.
14. Richards AM, Tonolo G, McIntyre GD, Leckie BJ, Robertson JI. Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and preextracted methods. J Hypertens 1987;5:227-36.
15. Cleland JGF, Ward S, Dutka D, Habib F, Impallomeni M, Morton JJ. Stability of plasma concentrations of n-terminal and c-terminal atrial natriuretic peptides at room-temperature. Heart 1996;75:410-13.
16. Choy AM, Darbar D, Lang CC, et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 1994;72:16-22.
17. Davidson NC, Naas AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptide, b-type natriuretic peptide, and n-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996;77:828-31.
18. Yamamoto K, Burnett JC, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94.
19. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996;76:232-7.
20. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD. Echocardiography in chronic heart failure in the community. Q J Med 1993;86: 17-23.
21. Francis CM, Caruana L, Kearney P, et al. Open access echocardiography in management of heart-failure in the community. BMJ 1995;310:634-6.